Literature DB >> 18787790

Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats.

Sheng-Ying Ye1, Wen-Yuan Gao.   

Abstract

Previous data demonstrated that hydroxysafflor yellow A (HSYA), a yellow color pigments extracted from the safflower, was an effective agent against focal cerebral ischemia. In the present study we demonstrated that HSYA prevented the injury in cultured cerebral cortical neurons induced by oxygen-glucose deprivation and increased the cell viability, as shown by the inhibition of both LDH and NO efflux. Further, HSYA administered orally 3 d before middle cerebral artery occlusion has the capacity to reduce cerebral infarct size and edema after 2 h cerebral ischemia followed by 24 h reperfusion in rats, and to significantly improve neurological behavior scores. Mean while, treatment with HSYA significantly decreased both mRNA and protein levels of IL-1beta, TNF-alpha in ischemic brain tissue. These results suggested that the protection of HSYA results from, at least in part, suppression of inflammatory responses following focal ischemia reperfusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787790     DOI: 10.1007/s12272-001-1261-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  13 in total

1.  Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors.

Authors:  Q Yang; Z-F Yang; S-B Liu; X-N Zhang; Y Hou; X-Q Li; Y-M Wu; A-D Wen; Ming-Gao Zhao
Journal:  Neurochem Res       Date:  2010-06-05       Impact factor: 3.996

2.  Genome-wide analysis and transcriptional reprogrammings of MYB superfamily revealed positive insights into abiotic stress responses and anthocyanin accumulation in Carthamus tinctorius L.

Authors:  Yingqi Hong; Naveed Ahmad; Jianyi Zhang; Yanxi Lv; Xinyue Zhang; Xintong Ma; Liu Xiuming; Yao Na
Journal:  Mol Genet Genomics       Date:  2022-01-03       Impact factor: 3.291

3.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Combination of Emricasan with Ponatinib Synergistically Reduces Ischemia/Reperfusion Injury in Rat Brain Through Simultaneous Prevention of Apoptosis and Necroptosis.

Authors:  Jing Tian; Shu Guo; Heng Chen; Jing-Jie Peng; Miao-Miao Jia; Nian-Sheng Li; Xiao-Jie Zhang; Jie Yang; Xiu-Ju Luo; Jun Peng
Journal:  Transl Stroke Res       Date:  2017-11-04       Impact factor: 6.829

5.  Hydroxysafflor yellow A improves learning and memory in a rat model of vascular dementia by increasing VEGF and NR1 in the hippocampus.

Authors:  Nan Zhang; Mengya Xing; Yiyi Wang; Hao Liang; Zhuo Yang; Fudong Shi; Yan Cheng
Journal:  Neurosci Bull       Date:  2013-08-23       Impact factor: 5.203

6.  Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits.

Authors:  Le-qun Shan; Sai Ma; Xiu-chun Qiu; Yong Zhou; Yong Zhang; Lian-he Zheng; Peng-cheng Ren; Yu-cai Wang; Qing-yu Fan; Bao-an Ma
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

7.  De novo transcriptome of safflower and the identification of putative genes for oleosin and the biosynthesis of flavonoids.

Authors:  Haiyan Li; Yuanyuan Dong; Jing Yang; Xiuming Liu; Yanfang Wang; Na Yao; Lili Guan; Nan Wang; Jinyu Wu; Xiaokun Li
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

8.  The Value of Safflower Yellow Injection for the Treatment of Acute Cerebral Infarction: A Randomized Controlled Trial.

Authors:  Le-Jun Li; Yu-Mei Li; Ben-Yu Qiao; Shan Jiang; Xin Li; Hong-Ming Du; Peng-Cheng Han; Jiong Shi
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

9.  Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.

Authors:  Xingtao Wang; Zhiyuan Ma; Zhongxiao Fu; Su Gao; Liu Yang; Yan Jin; Hui Sun; Chaoyun Wang; Weiming Fan; Lin Chen; Qing-Yin Zheng; Guoqiang Bi; Chun-Lei Ma
Journal:  ASN Neuro       Date:  2016-04-10       Impact factor: 4.146

Review 10.  Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.

Authors:  Hui Ao; Wuwen Feng; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.